The safety of glucocorticoids in the treatment of inflammatory rheumatic disease: new evidence.

Luís, Mariana; Boers, Maarten; Saag, Ken; Buttgereit, Frank; da Silva, José A P

Luís, Mariana; Boers, Maarten; Saag, Ken; Buttgereit, Frank; da Silva, José A P.

Afiliação

Luís M; Rheumatology Department, Centra Hospitalar e Universitário de Coimbra.
Boers M; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Saag K; Department of Epidemiology & Biostatistics, VU University Medical Center, Amsterdam.
Buttgereit F; Amsterdam Rheumatology and Immunology Center, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
da Silva JAP; Division of Clinical Immunology and Rheumatology, Center for Education and Research on Therapeutics University of Alabama at Birmingham, Birmingham, Alabama, USA.

Curr Opin Rheumatol ; 34(3): 179-186, 2022 05 01.

Article em En | MEDLINE | ID: mdl-35238807

Assuntos

Artrite Reumatoide; Glucocorticoides; Artrite Reumatoide/induzido quimicamente; Artrite Reumatoide/tratamento farmacológico; Glucocorticoides/efeitos adversos; Humanos; Prednisolona/uso terapêutico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Glucocorticoides Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans Idioma: En Revista: Curr Opin Rheumatol Assunto da revista: REUMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google